NMRA
Neumora·NASDAQ
--
--(--)
--
--(--)
NMRA fundamentals
Neumora (NMRA) released its earnings on Mar 30, 2026: revenue was 0 (YoY --), met estimates; EPS was -0.35 (YoY +5.41%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.35
+5.41%
Report date
Mar 30, 2026
NMRA Earnings Call Summary for Q4,2025
- Clinical Momentum: NMRA-511 shows best-in-class effect size in AD agitation; navacaprant Phase III enrollment complete with 800+ patients.
- Pipeline Expansion: NMRA-898 advances as lead M4 PAM for schizophrenia; NMRA-215 demonstrates class-leading DIO weight loss but faces delayed clinic start.
- Financial Strength: $182.5M cash runway to Q3 2027; 2025 net loss stable vs. prior year.
- Key Risks: NMRA-215 tox study delay; navacaprant approval dependent on single Phase III study success.
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Neumora (NMRA) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Neumora (NMRA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Neumora (NMRA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Neumora (NMRA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Neumora (NMRA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Neumora (NMRA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Neumora's management provide for the next earnings period?What is Neumora's gross profit margin?What were the key takeaways from Neumora’s earnings call?What is the market's earnings forecast for Neumora next quarter?What factors drove the changes in Neumora's revenue and profit?Did Neumora beat or miss consensus estimates last quarter?What does Neumora do and what are its main business segments?What is Neumora's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
